Initially, this patient had ER+ Her2+ invasive ductal carcinoma (IDC) in the left breast that was treated with standard local therapies over 2 years and this patient subsequently developed triple-negative IBC in the same breast [16] (Supplementary Information). Here, ERBB2 is linked to inflammatory breast carcinoma.